I den farmakokinetiske analyse med poolet population sås alder ikke at have nogen signifikant indflydelse på farmakokinetikken.
In the pooled population pharmacokinetic analysis, age was not found to influence the pharmacokinetics of rosiglitazone to any significant extent.